Prosigna®/pam50 en la toma de decisiones clinicas en pacientes con cancer de mama

Cover

Table of Contents

Table of Contents

Previous Page

12 / 31

Next Page

Information

Previous Page

12 / 31

Next Page

Page Background

ABCSG-8 trial

ROR defined groups (Prosigna) have

significant different outcomes after year 10

1 … 7 8 9 10 11 12 13 14 15 16 17 18 … 31 FlippingBook